ZA971667B - Serine protease inhibitors. - Google Patents
Serine protease inhibitors.Info
- Publication number
- ZA971667B ZA971667B ZA9701667A ZA971667A ZA971667B ZA 971667 B ZA971667 B ZA 971667B ZA 9701667 A ZA9701667 A ZA 9701667A ZA 971667 A ZA971667 A ZA 971667A ZA 971667 B ZA971667 B ZA 971667B
- Authority
- ZA
- South Africa
- Prior art keywords
- protease inhibitors
- serine protease
- serine
- inhibitors
- protease
- Prior art date
Links
- 239000003001 serine protease inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
- C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
- C07K5/06113—Asp- or Asn-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Crystallography & Structural Chemistry (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96200543 | 1996-03-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA971667B true ZA971667B (en) | 1997-09-10 |
Family
ID=8223736
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9701667A ZA971667B (en) | 1996-03-01 | 1997-02-26 | Serine protease inhibitors. |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US6410684B1 (cs) |
| EP (1) | EP0886647B1 (cs) |
| JP (1) | JP2000506837A (cs) |
| KR (1) | KR19990087415A (cs) |
| CN (1) | CN1212704A (cs) |
| AR (1) | AR006310A1 (cs) |
| AT (1) | ATE221080T1 (cs) |
| AU (1) | AU709330B2 (cs) |
| BR (1) | BR9707808A (cs) |
| CA (1) | CA2246246A1 (cs) |
| CZ (1) | CZ277898A3 (cs) |
| DE (1) | DE69714222T2 (cs) |
| DK (1) | DK0886647T3 (cs) |
| ES (1) | ES2180933T3 (cs) |
| HU (1) | HUP9900390A3 (cs) |
| IL (1) | IL120310A (cs) |
| NO (1) | NO983991L (cs) |
| NZ (1) | NZ331484A (cs) |
| PL (1) | PL328875A1 (cs) |
| PT (1) | PT886647E (cs) |
| RU (1) | RU2178419C2 (cs) |
| TR (1) | TR199801704T2 (cs) |
| TW (1) | TW442452B (cs) |
| WO (1) | WO1997031937A1 (cs) |
| ZA (1) | ZA971667B (cs) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR19990082424A (ko) * | 1996-02-13 | 1999-11-25 | 이.에이치. 리링크 | 세린 프로테아제 억제제 |
| JP2001525823A (ja) | 1997-05-15 | 2001-12-11 | イーライ・リリー・アンド・カンパニー | 抗血栓化合物 |
| EA003856B1 (ru) | 1998-04-30 | 2003-10-30 | Агурон Фармасьютикалз, Инк. | Антипикорнавирусные композиции, их получение и применение |
| WO2000009542A1 (en) * | 1998-08-17 | 2000-02-24 | Cortech, Inc. | SERINE PROTEASE INHIBITORS COMPRISING α-KETO HETEROCYCLES |
| WO2000051623A2 (en) | 1999-03-05 | 2000-09-08 | The Trustees Of University Technology Corporation | Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide-induced clinical conditions |
| US7704958B1 (en) | 1999-03-05 | 2010-04-27 | Bio Holding, Inc. | Methods and compositions for inhibiting apoptosis using serine protease inhibitors |
| US6849605B1 (en) | 1999-03-05 | 2005-02-01 | The Trustees Of University Technology Corporation | Inhibitors of serine protease activity, methods and compositions for treatment of viral infections |
| DK1206484T3 (da) | 1999-08-04 | 2005-01-24 | Agouron Pharma | Antipicornavirale forbindelser og sammensætninger, deres farmaceutiske anvendelser og materialer til deres syntese |
| AU2001266924A1 (en) | 2000-06-14 | 2001-12-24 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| KR100904788B1 (ko) | 2000-07-21 | 2009-06-25 | 쉐링 코포레이션 | Ｃ형 간염 바이러스의 ｎｓ3-세린 프로테아제억제제로서의 신규한 펩티드 |
| NZ523781A (en) * | 2000-07-21 | 2004-10-29 | Corvas Int Inc | Novel peptides as NS3-serine protease inhibitors of hepatitis C virus |
| US7244721B2 (en) | 2000-07-21 | 2007-07-17 | Schering Corporation | Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| EP1358178A2 (en) | 2001-01-30 | 2003-11-05 | Bristol-Myers Squibb Company | Sulfonamide lactam inhibitors of factor xa |
| US7405210B2 (en) * | 2003-05-21 | 2008-07-29 | Osi Pharmaceuticals, Inc. | Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase |
| JP2007527904A (ja) | 2004-03-08 | 2007-10-04 | プロシディオン・リミテッド | グリコーゲンホスホリラーゼ阻害剤としてのピロロピリジン−２−カルボン酸ヒドラジド化合物 |
| JP2008521873A (ja) | 2004-12-02 | 2008-06-26 | プロシディオン・リミテッド | ピロロピリジン−２−カルボン酸アミド類 |
| JP5740308B2 (ja) * | 2008-10-15 | 2015-06-24 | ダニスコ・ユーエス・インク | 修飾変異ボウマンブリックプロテアーゼインヒビター |
| FI3472149T3 (fi) | 2016-06-21 | 2023-11-09 | Orion Ophthalmology LLC | Heterosyklisiä prolinamidijohdannaisia |
| US10526315B2 (en) | 2016-06-21 | 2020-01-07 | Orion Ophthalmology LLC | Carbocyclic prolinamide derivatives |
| US11351149B2 (en) | 2020-09-03 | 2022-06-07 | Pfizer Inc. | Nitrile-containing antiviral compounds |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4556655A (en) * | 1984-09-24 | 1985-12-03 | Schering Corporation | Antihypertensive compounds having both diuretic and angiotensin converting enzyme inhibitory activity |
| CA2008116C (en) * | 1989-02-23 | 2001-11-20 | Thomas Weller | Glycine derivatives |
| ZW11290A1 (en) * | 1989-07-14 | 1990-10-31 | Smithkline Beecham Corp | Hemoregulatory peptides |
| DE69431718T2 (de) * | 1993-04-30 | 2003-07-10 | Merck & Co., Inc. | Thrombin-inhibitoren |
| US5672582A (en) * | 1993-04-30 | 1997-09-30 | Merck & Co., Inc. | Thrombin inhibitors |
| SE9301916D0 (sv) | 1993-06-03 | 1993-06-03 | Ab Astra | New peptides derivatives |
| ZA951618B (en) | 1994-03-04 | 1996-08-27 | Lilly Co Eli | Antithrombotic agents |
| ZA951617B (en) | 1994-03-04 | 1997-02-27 | Lilly Co Eli | Antithrombotic agents. |
| US5561146A (en) | 1994-06-10 | 1996-10-01 | Bristol-Myers Squibb Company | Modified guanidino and amidino thrombin inhibitors |
| WO1995035311A1 (en) | 1994-06-17 | 1995-12-28 | Corvas International, Inc. | 3-amino-2-oxo-1-piperidineacetic derivatives as enzyme inhibitors |
| JPH0820597A (ja) * | 1994-07-07 | 1996-01-23 | Meiji Seika Kaisha Ltd | トロンビン阻害作用を有する複素環カルボニル化合物 |
| CA2208772A1 (en) | 1994-12-22 | 1996-06-27 | Benoit Bachand | Low molecular weight bicyclic thrombin inhibitors |
-
1997
- 1997-02-25 TW TW086102261A patent/TW442452B/zh not_active IP Right Cessation
- 1997-02-25 IL IL12031097A patent/IL120310A/en not_active IP Right Cessation
- 1997-02-26 TR TR1998/01704T patent/TR199801704T2/xx unknown
- 1997-02-26 AU AU18775/97A patent/AU709330B2/en not_active Ceased
- 1997-02-26 BR BR9707808A patent/BR9707808A/pt not_active Application Discontinuation
- 1997-02-26 PT PT97905099T patent/PT886647E/pt unknown
- 1997-02-26 CA CA002246246A patent/CA2246246A1/en not_active Abandoned
- 1997-02-26 DE DE69714222T patent/DE69714222T2/de not_active Expired - Fee Related
- 1997-02-26 CZ CZ982778A patent/CZ277898A3/cs unknown
- 1997-02-26 HU HU9900390A patent/HUP9900390A3/hu unknown
- 1997-02-26 ZA ZA9701667A patent/ZA971667B/xx unknown
- 1997-02-26 RU RU98117949/04A patent/RU2178419C2/ru active
- 1997-02-26 AT AT97905099T patent/ATE221080T1/de not_active IP Right Cessation
- 1997-02-26 PL PL97328875A patent/PL328875A1/xx unknown
- 1997-02-26 NZ NZ331484A patent/NZ331484A/xx unknown
- 1997-02-26 DK DK97905099T patent/DK0886647T3/da active
- 1997-02-26 CN CN97192682A patent/CN1212704A/zh active Pending
- 1997-02-26 KR KR1019980706833A patent/KR19990087415A/ko not_active Ceased
- 1997-02-26 WO PCT/EP1997/000938 patent/WO1997031937A1/en not_active Application Discontinuation
- 1997-02-26 EP EP97905099A patent/EP0886647B1/en not_active Expired - Lifetime
- 1997-02-26 ES ES97905099T patent/ES2180933T3/es not_active Expired - Lifetime
- 1997-02-26 US US09/142,110 patent/US6410684B1/en not_active Expired - Fee Related
- 1997-02-26 JP JP9530600A patent/JP2000506837A/ja not_active Ceased
- 1997-03-03 AR ARP970100833A patent/AR006310A1/es unknown
-
1998
- 1998-08-31 NO NO983991A patent/NO983991L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2180933T3 (es) | 2003-02-16 |
| DE69714222T2 (de) | 2003-02-20 |
| AU1877597A (en) | 1997-09-16 |
| EP0886647A1 (en) | 1998-12-30 |
| HK1021541A1 (en) | 2000-06-16 |
| AU709330B2 (en) | 1999-08-26 |
| JP2000506837A (ja) | 2000-06-06 |
| IL120310A0 (en) | 1997-06-10 |
| PL328875A1 (en) | 1999-03-01 |
| PT886647E (pt) | 2002-12-31 |
| AR006310A1 (es) | 1999-08-25 |
| NO983991D0 (no) | 1998-08-31 |
| IL120310A (en) | 2002-02-10 |
| HUP9900390A2 (hu) | 1999-06-28 |
| EP0886647B1 (en) | 2002-07-24 |
| WO1997031937A1 (en) | 1997-09-04 |
| CZ277898A3 (cs) | 1999-06-16 |
| ATE221080T1 (de) | 2002-08-15 |
| KR19990087415A (ko) | 1999-12-27 |
| TW442452B (en) | 2001-06-23 |
| NO983991L (no) | 1998-10-30 |
| NZ331484A (en) | 2000-01-28 |
| DE69714222D1 (de) | 2002-08-29 |
| RU2178419C2 (ru) | 2002-01-20 |
| DK0886647T3 (da) | 2002-11-04 |
| US6410684B1 (en) | 2002-06-25 |
| TR199801704T2 (xx) | 1998-12-21 |
| CA2246246A1 (en) | 1997-09-04 |
| BR9707808A (pt) | 1999-07-27 |
| CN1212704A (zh) | 1999-03-31 |
| HUP9900390A3 (en) | 2000-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA992447B (en) | Quinoxalinones as serine protease inhibitors. | |
| ZA983629B (en) | Serine protease inhibitors | |
| IL131661A0 (en) | Protease inhibitors | |
| AU7127298A (en) | Serine protease inhibitors | |
| HUP9901187A3 (en) | Serine protease inhibitors | |
| ZA992448B (en) | Quinoxalinones as serine protease inhibitors. | |
| ZA971733B (en) | Serine protease inhibitors. | |
| PL337755A1 (en) | Protease inhibitors | |
| ZA971667B (en) | Serine protease inhibitors. | |
| ZA983522B (en) | Protease inhibitors | |
| IL132088A0 (en) | Protease inhibitors | |
| EP1093367A4 (en) | PROTEASE INHIBITORS | |
| PL328223A1 (en) | Aspartil protease inhibitors | |
| ZA988479B (en) | Protease inhibitors | |
| EP1067894A4 (en) | PROTHEASEINHIBITOREN | |
| EP1079821A4 (en) | PROTEASE INHIBITORS | |
| GB9800817D0 (en) | Serine protease inhibitors | |
| ZA988064B (en) | Protease inhibitors | |
| GB9603217D0 (en) | Serine protease inhibitors | |
| EP1086083A4 (en) | PROTEASE INHIBITORS | |
| EP1140897A4 (en) | PROTEASE INHIBITORS | |
| EP0975612A4 (en) | PROTEASE INHIBITORS | |
| GB9613719D0 (en) | Serine protease inhibitors | |
| ZA971178B (en) | Serine protease inhibitors. | |
| HK1026439A (en) | Serine protease inhibitors |